AGIO

Agios Pharmaceuticals
AGIO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.67B
EV
$192.28M
Shares Outstanding
57.30M
Beta
0.83

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$53.17
P/E 2025E
-
P/Revenue 2025E
33.59x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Agios Pharmaceuticals, Inc.

gainify
AGIO

Agios Pharmaceuticals, Inc.

AGIO

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for ...

Sector

Healthcare

Industry

Biotechnology

CEO

Goff, Brian

Employees

487

IPO Date

2013-07-24

Headquarters

88 Sidney Street, Cambridge, Massachusetts, 02139, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved